SEC Tracker
Get the app

Olema Pharmaceuticals OLMA

Ian T Clark (Director) plans to sell 264,800 OLMA shares, about $7.9M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Dec 19, 2025
  2. Broker: Fidelity Brokerage Services LLC
  3. Shares acquired by: Option Granted - 08/12/2020; Option Granted - 06/17/2022; Option Granted - 06/16/2023; Option Granted - 06/11/2025

All of Ian T Clark's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 29,904 shares at $28.83 on Dec 19, 2025 · Form 4
  • Sold 193,056 shares at $29.71 on Dec 19, 2025 · Form 4
  • Sold 41,840 shares at $30.48 on Dec 19, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Olema Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Annexon ANNX public float $244M, Jun 30, 2025
  2. DBV Technologies DBVT public float $251M, Jun 30, 2025
  3. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  4. Corvus Pharmaceuticals CRVS public float $252M, Jun 30, 2025
  5. Verastem VSTM public float $254M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.